Skip to main content

Table 1 Summary of the genetic abnormalities detected in pre-invasive lesions of the breasta

From: The diagnosis and management of pre-invasive breast disease Genetic alterations in pre-invasive lesions

Lesion

Method

Gainsb

Losses / LOH / AIb

Reference

Normal cells

LOH

-

2pter, 16q23.1-24.2, 17q21, 17q24

17

 

LOH

-

9p, 11p, 13q, 16q, 17p

56

 

LOH

-

3p24, 11p15.5, 17p13.1

60

 

LOH

-

1q, 7q, 11p, 16q, 17q

61

 

LOH

-

11p, 13q

63

 

LOH

-

3p24.3

64

HUT

CGH

No

No

6

 

LOH

-

2pter, 2q35, 4q25, 6qter, 8p, 9p, 11p15, 11q23, 13q13, 14q24, 16q21, 17p13, 17q11, 17q21, 17q25

13

 

CGH

1q+, 1q32-42+, 12+, 17q21+, 20+

8-, 8p12-pter-, 9-, 10p-, 11q14-qter-, 18-, X-, 16q-, 17p-, 20p-

54

 

LOH

-

16q, 17p, 17q

55

 

LOH

-

9p, 11p, 13q, 16q, 17q

56

 

CGH

13q

1p, 16p, 17q, 19p, 22q

57

ADH

LOH

-

2pter, 2q35, 6qter, 8p, 9p, 11p15, 11q23, 13q13, 14q24, 16q21, 17p13, 17q11, 17q21,

13

 

LOH

-

17q25, 16q, 17p

52

 

LOH

-

8p, 16q, 17q

53

 

CGH

1q, 10, 16p, 8q21-qter, 14q

3q11-q21, 8p12-pter, 16q,20, 11q12-13, 16q 16q, 20p, 16q, 17p, 21q11-q21, 16q, 17p

54

ALH/LCIS

CGH

1q, 1q21-q32, 1q25-qter, 8p11-p12, 12q14-q21

7p, 8p, 8p21-pter, 12q24, 16q, 17p, 13q12-q21; 16q; 17p12-p13

31

 

CGH

6q

16p, 16q, 17p, 22q

32

Columnar cell change/clinging ca

LOH

-

2p, 3p, 11q, 11q, 16q, 16q, 17q, 17q

60

DCISc

See text

See text

See text

See text

  1. -, none. aFor LOH analyses, only those studies in which more than one chromosomal arm was evaluated were included in the table. bAll chromosomal gains and losses reported in the cited studies (references) were included. For the frequency of each genetic abnormality, please see text and cited references. cDCIS of different grades harbour distinct chromosomal abnormalities. Genetic abnormalities of nearly all chromosomal arms have been reported in high-grade DCIS. See text for details. ADH, atypical ductal hyperplasia; AI, allelic imbalance; ALH/LCIS, atypical lobular hyperplasia/lobular carcinoma in situ; Columnar cell change/ clinging ca, columnar cell change/clinging carcinoma; DCIS, ductal carcinoma in situ; HUT, hyperplasia of usual type; LOH, loss of heterozygosity.